American Cancer Society’s new partnership with Janus Henderson Investors!

American Cancer Society shared on LinkedIn:

“We’re honored to announce that our new partner Janus Henderson Investors is backing our mission to end cancer as we know it, for everyone! Through this pioneering initiative, part of every dollar (one-half of the management fees) invested into the Janus Henderson Government Money Market Fund is also invested into the American Cancer Society mission. We are grateful to Janus Henderson for demonstrating their commitment to our vision. Together, we are making a real difference! Learn more.”

Karen Knudsen added a comment:

“We are excited to announce our new partnership with Janus Henderson Investors! Together, we are breaking new ground in the fight against cancer. Their generous support will increase our ability to advance cancer research and get us closer to our vision of ending cancer as we know it, for everyone.”

Source: American Cancer Society/LinkedIn and Karen Knudsen/LinkedIn

Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.

She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR). She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.